Johnson & Johnson’s settlement

“Consumers rely on accurate information when making decisions about which products to purchase for their families,” Illinois Attorney General Kwame Raoul, one of 43 attorneys general involved in the lawsuit, said in a statement Tuesday. “Any company — no matter how large — must be held accountable when laws protecting consumers are broken and their trust is violated.”

As part of the settlement, which is still pending judicial approval, the health products giant will permanently stop the manufacturing, promotion and sale of all of its baby powder and other body and cosmetic products that contain talcum powder. That includes Johnson’s Baby Powder and Johnson & Johnson’s Shower to Shower. The company decided to pull talc-based powders off the market in North America in 2020.

J&J’s lawsuit

J&J did not admit wrongdoing in settling with the states, which were led by Florida, North Carolina and Texas, and has said its talc products are safe and do not cause cancer. The company announced a settlement in principle in January.

“This is a major advancement for consumer product safety,” Florida Attorney General Ashley Moody said in a statement.

J&J still faces tens of thousands of talc lawsuits, and a class action accusing the New Brunswick, New Jersey-based company of fraudulently hiding their dangers from shareholders.

J&J’s talc payout for cancer

As of March 31, about 61,490 people were still suing J&J over talc. Most were women with ovarian cancer, while a smaller number had mesothelioma, a type of cancer linked to asbestos.

J&J stopped selling talc-based baby powder globally last year, switching to corn starch as the main ingredient. It has maintained that its products do not contain asbestos.

J&J’s attempt to resolve litigation

The company has twice tried to resolve the litigation by placing into bankruptcy a subsidiary it created to contain its talc liabilities, but courts rebuffed both attempts.

On May 1, J&J proposed a $6.48 billion settlement to resolve most of the litigation through a third bankruptcy filing. It has set aside an $11 billion reserve to cover all talc liabilities.

“The company continues to pursue several paths to achieve a comprehensive and final resolution of the talc litigation,” Erik Haas, J&J worldwide vice president of litigation, said in a statement on Tuesday.

“We will continue to address the claims of those who do not want to participate in our contemplated consensual bankruptcy resolution through litigation or settlement,” he added.

The post Johnson & Johnson Agrees to $700M Settlement Over Talc Safety Case appeared first on Industry Leaders Magazine.